0,959  0,002  Aldehyde oxidase inhibitor
0,862  0,003  CTGF expression inhibitor
0,846  0,005  Caspase 9 stimulant
0,843  0,004  UGT1A6 substrate
0,795  0,004  UGT1A9 substrate
0,733  0,007  CYP1A2 substrate
0,721  0,011  CYP2C9 substrate
0,708  0,007  CYP2C19 substrate
0,648  0,003  Aldehyde oxidase substrate
0,657  0,013  Respiratory analeptic
0,679  0,034  Apoptosis agonist
0,631  0,004  FMO1 substrate
0,622  0,010  Cardiovascular analeptic
0,619  0,013  Sensitization
0,611  0,010  Antioxidant
0,615  0,029  Transcription factor NF kappa B inhibitor
0,585  0,005  Tubulin antagonist
0,585  0,007  Superoxide dismutase inhibitor
0,574  0,004  UGT2B4 substrate
0,580  0,012  Cardioprotectant
0,589  0,030  CYP3A4 substrate
0,557  0,006  Monophenol monooxygenase inhibitor
0,558  0,008  Antimutagenic
0,586  0,037  Antineoplastic (breast cancer)
0,551  0,005  Anesthetic general
0,561  0,017  Mutagenic
0,562  0,018  Aryl hydrocarbon receptor agonist
0,569  0,029  15-Lipoxygenase inhibitor
0,537  0,004  Alpha tubulin antagonist
0,549  0,018  Analeptic
0,525  0,002  Alcohol dehydrogenase substrate
0,533  0,013  Free radical scavenger
0,525  0,014  Antiprotozoal (Leishmania)
0,570  0,061  Alpha-glucosidase inhibitor
0,526  0,017  Caspase 3 stimulant
0,525  0,018  Cytostatic
0,513  0,009  Antihypoxic
0,521  0,022  CYP2D6 substrate
0,491  0,001  Aldehyde dehydrogenase substrate
0,524  0,036  GST A substrate
0,526  0,040  TNF expression inhibitor
0,503  0,021  12-Lipoxygenase inhibitor
0,493  0,012  Skin irritative effect
0,490  0,010  Peroxidase inhibitor
0,495  0,018  Antineoplastic (non-small cell lung cancer)
0,482  0,008  Melanin inhibitor
0,516  0,042  Antineoplastic (lung cancer)
0,474  0,005  Pneumotoxic
0,506  0,039  Antileukemic
0,490  0,025  Ulceration
0,477  0,021  NOS2 expression inhibitor
0,532  0,077  DNA polymerase beta inhibitor
0,460  0,005  UGT2B15 substrate
0,459  0,008  Genotoxic
0,470  0,024  Apoptosis antagonist
0,447  0,006  GST P1-1 substrate
0,443  0,010  Skin whitener
0,503  0,081  DNA directed DNA polymerase inhibitor
0,426  0,005  Aldehyde dehydrogenase inhibitor
0,424  0,004  Histidine decarboxylase inhibitor
0,426  0,010  5 Hydroxytryptamine uptake stimulant
0,447  0,031  Cytotoxic
0,433  0,017  UDP-glucuronosyltransferase substrate
0,443  0,030  Antineoplastic (cervical cancer)
0,448  0,034  Antihypercholesterolemic
0,455  0,043  Antineoplastic (colorectal cancer)
0,440  0,028  Carcinogenic
0,452  0,041  Antineoplastic (colon cancer)
0,451  0,041  Prostate cancer treatment
0,415  0,005  Neurotrophic factor enhancer
0,425  0,020  Antimitotic
0,432  0,030  Lipoxygenase inhibitor
0,435  0,034  Antineoplastic (melanoma)
0,453  0,059  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,427  0,033  Radioprotector
0,420  0,026  Chemopreventive
0,414  0,023  Amyloid beta aggregation inhibitor
0,407  0,019  Pyruvate kinase inhibitor
0,420  0,035  AR expression inhibitor
0,383  0,004  Beta tubulin antagonist
0,379  0,002  UGT2B10 substrate
0,425  0,050  CYP2C19 inhibitor
0,377  0,003  Toll-Like receptor 2 antagonist
0,374  0,004  Macrophage migration inhibitory factor inhibitor
0,372  0,003  Xanthine oxidase substrate
0,378  0,011  Tyrosine 3 hydroxylase inhibitor
0,393  0,030  Radiosensitizer
0,366  0,005  UGT2B9 substrate
0,365  0,006  Antifungal enhancer
0,363  0,005  Xanthine oxidase inhibitor
0,367  0,012  Lipid peroxidase inhibitor
0,376  0,024  Antihypertriglyceridemic
0,356  0,005  Beta glucuronidase inhibitor
0,382  0,032  DNA damaging
0,387  0,039  Antineoplastic (glioma)
0,375  0,028  Nitric oxide antagonist
0,374  0,034  Antiamyloidogenic
0,359  0,020  GST M1-1 substrate
0,367  0,030  Antineoplastic (osteosarcoma)
0,352  0,015  Antineoplastic (squamous cell carcinoma)
0,351  0,014  Phospholipase C inhibitor
0,353  0,017  UGT2B7 substrate
0,341  0,006  Succinate dehydrogenase inhibitor
0,367  0,033  Antineoplastic (glioblastoma multiforme)
0,382  0,051  Antifungal
0,334  0,007  Expectorant
0,373  0,046  Spasmolytic
0,336  0,009  Sulfotransferase substrate
0,353  0,033  Antineoplastic (liver cancer)
0,360  0,043  Calcium channel activator
0,346  0,033  Flavin-containing monooxygenase substrate
0,348  0,041  Antipyretic
0,373  0,067  Thioredoxin glutathione reductase inhibitor
0,319  0,014  Protein kinase stimulant
0,342  0,038  Antineoplastic (renal cancer)
0,328  0,026  UGT1A1 substrate
0,385  0,084  Antibacterial
0,320  0,020  DNA methyltransferase I inhibitor
0,384  0,084  Histamine release inhibitor
0,307  0,009  Gout treatment
0,318  0,021  VCAM1 expression inhibitor
0,342  0,045  CYP1A2 inhibitor
0,384  0,088  5 Hydroxytryptamine release inhibitor
0,380  0,087  Antiparkinsonian
0,310  0,020  UGT1A3 substrate
0,307  0,019  Interferon gamma antagonist
0,293  0,006  Mannose-6-phosphate isomerase inhibitor
0,304  0,018  Amylase inhibitor
0,308  0,022  Antiseptic
0,290  0,005  HIV-1 integrase (3'-Processing) inhibitor
0,289  0,005  NAD(P)H dehydrogenase (quinone) inhibitor
0,343  0,058  Antimycobacterial
0,287  0,005  Mucolytic
0,294  0,013  3C-like protease (Human coronavirus) inhibitor
0,291  0,010  Cystathionine beta-synthase inhibitor
0,328  0,047  FMO3 substrate
0,346  0,066  Cholesterol antagonist
0,284  0,005  Movement disorders treatment
0,328  0,049  Antineoplastic (small cell lung cancer)
0,328  0,050  Antineoplastic (multiple myeloma)
0,330  0,053  Hypoxia-inducible factor 1 alpha inhibitor
0,290  0,014  Nitric-oxide synthase stimulant
0,335  0,061  Antineoplastic (ovarian cancer)
0,303  0,029  Hepatoprotectant
0,279  0,006  Porphobilinogen synthase inhibitor
0,302  0,030  UGT1A4 substrate
0,334  0,063  Vasodilator, coronary
0,300  0,030  Antihypotensive
0,330  0,061  5 Hydroxytryptamine release stimulant
0,297  0,029  DNA methylase inhibitor
0,290  0,022  MAO inhibitor
0,318  0,052  Chemoprotective
0,292  0,026  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,328  0,062  NOS3 expression inhibitor
0,320  0,057  Antituberculosic
0,333  0,070  ICAM1 expression inhibitor
0,266  0,004  GABA aminotransferase inhibitor
0,269  0,007  Carbonic anhydrase XIII inhibitor
0,309  0,048  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,324  0,063  Antineoplastic (brain cancer)
0,264  0,005  HIV-1 integrase (Strand Transfer) inhibitor
0,258  0,002  Granulocyte macrophage colony stimulating factor agonist
0,341  0,086  Prostaglandin dehydrogenase inhibitor
0,271  0,017  M18 aspartyl aminopeptidase inhibitor
0,280  0,027  Mcl-1 antagonist
0,264  0,012  Carcinogenic, group 2B
0,262  0,014  SULT1A3 substrate
0,262  0,018  Alkaline phosphatase inhibitor
0,275  0,034  Dual specificity phosphatase 3 inhibitor
0,258  0,016  Carcinogenic, group 1
0,267  0,027  Antineoplastic (carcinoma)
0,267  0,028  Antianorexic
0,258  0,025  Muscular dystrophy treatment
0,256  0,024  Heat shock protein 90 alpha antagonist
0,241  0,012  Antieczematic
0,261  0,032  CYP2B6 inhibitor
0,256  0,028  Anesthetic
0,284  0,058  Proliferative diseases treatment
0,248  0,023  Alpha-N-acetylglucosaminidase inhibitor
0,239  0,019  VEGF expression inhibitor
0,232  0,012  SULT1A1 substrate
0,261  0,041  Antihelmintic
0,232  0,015  Antibacterial (Helicobacter pylori)
0,224  0,007  TRPA1 agonist
0,217  0,003  UGT2B11 substrate
0,267  0,054  Antiparasitic
0,217  0,004  Purinergic P2X2 antagonist
0,232  0,019  MAO B inhibitor
0,250  0,038  Dual specificity phosphatase inhibitor
0,273  0,062  Dyrk kinase inhibitor
0,284  0,075  Antineoplastic (pancreatic cancer)
0,269  0,061  Cardiodepressant
0,240  0,034  Tumour necrosis factor antagonist
0,227  0,022  Antihyperlipoproteinemic
0,311  0,109  GABA C receptor rho-3 antagonist
0,230  0,028  Topoisomerase II inhibitor
0,273  0,072  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,228  0,027  Heat shock protein 90 antagonist
0,199  0,003  Catechol O-methyltransferase inhibitor
0,205  0,008  Thioredoxin inhibitor
0,342  0,146  Antineoplastic (solid tumors)
0,247  0,051  RNA-directed DNA polymerase inhibitor
0,216  0,021  Neurotrophic factor
0,239  0,048  Antiviral (West Nile virus)
0,241  0,050  Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor
0,195  0,007  DOPA decarboxylase inhibitor
0,274  0,087  Immunostimulant
0,213  0,026  Toll-Like receptor antagonist
0,200  0,014  Antineoplastic alkaloid
0,256  0,071  Myocardial infarction treatment
0,189  0,005  Antifungal (Pneumocystis)
0,211  0,027  Antirickettsial
0,231  0,047  Insulin sensitizer
0,247  0,062  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,249  0,069  Antineoplastic (sarcoma)
0,214  0,034  Carcinogenic, group 3
0,223  0,043  Eye irritation, high
0,203  0,024  Antitussive
0,247  0,068  DNA synthesis inhibitor
0,224  0,047  Antipruritic, non-allergic
0,201  0,024  5-Lipoxygenase inhibitor
0,190  0,015  Vanilloid 1 agonist
0,251  0,076  Teratogen
0,208  0,034  Antineoplastic (bone cancer)
0,245  0,070  Antineoplastic (lymphocytic leukemia)
0,178  0,005  Estradiol 17 beta-dehydrogenase inhibitor
0,178  0,005  Xanthine dehydrogenase inhibitor
0,214  0,043  LDLR expression enhancer
0,242  0,072  Calpain inhibitor
0,258  0,089  Insulysin inhibitor
0,201  0,032  Arachidonic acid antagonist
0,224  0,058  Abortion inducer
0,276  0,110  Vasodilator, peripheral
0,184  0,018  Interleukin 8 antagonist
0,175  0,009  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,289  0,128  Antipruritic, allergic
0,180  0,020  UGT2B1 substrate
0,270  0,109  Angiogenesis inhibitor
0,189  0,029  Alkylator
0,171  0,012  CYP2A6 inhibitor
0,212  0,053  Histone acetyltransferase inhibitor
0,268  0,110  Sodium/bile acid cotransporter inhibitor
0,163  0,006  Purinergic P2X1 antagonist
0,169  0,013  Estrogen receptor beta antagonist
0,181  0,025  Adenylate cyclase stimulant
0,170  0,015  Phosphofructokinase-1 inhibitor
0,191  0,037  NADPH oxidase inhibitor
0,171  0,017  Estrogen antagonist
0,217  0,064  Antiviral (Influenza)
0,162  0,011  Paget's disease treatment
0,229  0,080  Embryotoxic
0,218  0,069  Antialcoholic
0,169  0,021  Antineoplastic (uterine cancer)
0,168  0,023  Contraceptive female
0,157  0,012  Glutamate decarboxylase inhibitor
0,194  0,050  Acaricide
0,174  0,031  Antihemorrhagic
0,146  0,003  Glucose-6-phosphate translocase inhibitor
0,166  0,026  Carbonic anhydrase XV inhibitor
0,161  0,021  Topoisomerase II alpha inhibitor
0,150  0,011  Ornithine decarboxylase inhibitor
0,173  0,034  Topoisomerase I inhibitor
0,153  0,014  Keratolytic
0,143  0,005  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,163  0,027  Gastritis treatment
0,186  0,050  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,159  0,025  Carbonic anhydrase III inhibitor
0,215  0,083  Antineoplastic (lymphoma)
0,166  0,035  Antihelmintic (Trematoda)
0,166  0,035  Glutathione S-transferase substrate
0,160  0,028  Heat shock protein 70 antagonist
0,183  0,052  Antiviral (Influenza A)
0,142  0,011  Alcohol oxidase inhibitor
0,187  0,057  Antihelmintic (Nematodes)
0,157  0,028  Ca2+-transporting ATPase inhibitor
0,150  0,022  Carcinogenic, group 2A
0,160  0,032  Coagulant
0,138  0,010  HIV-1 integrase inhibitor
0,180  0,054  Phospholipase A2 inhibitor
0,171  0,045  CF transmembrane conductance regulator agonist
0,147  0,022  Actinic keratosis treatment
0,176  0,051  CDC-like kinase 1 inhibitor
0,148  0,024  Breast cancer-resistant protein inhibitor
0,151  0,028  UDP-glucose 4-epimerase inhibitor
0,217  0,095  Tumour necrosis factor alpha release inhibitor
0,162  0,039  Cyclooxygenase 3 inhibitor
0,161  0,039  Cholesterol synthesis inhibitor
0,285  0,163  Transcription factor inhibitor
0,143  0,022  Protein kinase C zeta inhibitor
0,152  0,030  Protein kinase C gamma inhibitor
0,136  0,014  Estrogen receptor alpha antagonist
0,146  0,025  Creatine kinase inhibitor
0,167  0,046  Antianemic
0,150  0,029  Antihelmintic (Fasciola)
0,141  0,023  Carbonic anhydrase VI inhibitor
0,125  0,007  Antimycoplasmal
0,170  0,053  Aldose reductase substrate
0,143  0,025  Electron transport complex I inhibitor
0,140  0,023  Anabolic
0,223  0,108  Antiosteoporotic
0,151  0,037  Microtubule formation inhibitor
0,265  0,151  Antiprotozoal
0,217  0,105  Interleukin agonist
0,167  0,054  GABA C receptor rho-2 antagonist
0,128  0,016  Aromatase inhibitor
0,121  0,010  Estrogen-related receptor beta agonist
0,147  0,036  Sphingosine 1-phosphate receptor 4 antagonist
0,140  0,029  HIV-1 integrase (Overall Integration) inhibitor
0,145  0,035  Choleretic
0,118  0,008  GABA B receptor agonist
0,142  0,034  Bronchodilator
0,129  0,022  Antidote, mercury
0,114  0,008  Topoisomerase II beta inhibitor
0,109  0,003  GABA transporter 3 inhibitor
0,110  0,005  Squalene epoxidase inhibitor
0,147  0,042  MAO A inhibitor
0,190  0,086  Psychostimulant
0,279  0,175  Calcium channel L-type activator
0,124  0,021  Glutamate dehydrogenase inhibitor
0,105  0,003  Pregnane X receptor antagonist
0,167  0,065  Uterine stimulant
0,119  0,019  Vanilloid agonist
0,165  0,065  Protein-tyrosine phosphatase inhibitor
0,137  0,037  Falcipain inhibitor
0,135  0,036  Falcipain 2 inhibitor
0,151  0,052  Cocaine dependence treatment
0,169  0,072  ATPase inhibitor
0,113  0,016  SULT1A2 substrate
0,151  0,054  Acetylcholinesterase inhibitor
0,194  0,098  Cyclic AMP phosphodiesterase inhibitor
0,113  0,017  D-Ala-D-Ala ligase inhibitor
0,098  0,004  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,169  0,076  Phobic disorders treatment
0,128  0,034  CDC-like kinase 3 inhibitor
0,121  0,029  SULT1E1 substrate
0,112  0,020  Sphingosine 1-phosphate receptor 4 agonist
0,123  0,033  Alcohol dehydrogenase inhibitor
0,103  0,014  Endocannabinoid uptake inhibitor
0,205  0,117  Antiprotozoal (Trypanosoma)
0,117  0,030  NADH dehydrogenase inhibitor
0,104  0,017  Aldose reductase inhibitor
0,122  0,037  Prolactin inhibitor
0,221  0,135  Bone diseases treatment
0,125  0,040  Antiprotozoal (Toxoplasma)
0,107  0,022  Phenylalanine 4-hydroxylase inhibitor
0,161  0,077  Neurotensin receptor agonist
0,283  0,199  MAP kinase 1 inhibitor
0,118  0,034  Androgen antagonist
0,094  0,011  Botulinum neurotoxin type A inhibitor
0,127  0,045  GABA C receptor agonist
0,205  0,125  5 Hydroxytryptamine 1E antagonist
0,085  0,008  Vanilloid 2 antagonist
0,139  0,061  Interleukin 4 antagonist
0,113  0,037  Triose-phosphate isomerase inhibitor
0,121  0,044  Urease inhibitor
0,133  0,057  Adenylate cyclase inhibitor
0,115  0,039  Antifungal (Aspergillus)
0,132  0,056  Papain-like protease (SARS coronavirus) inhibitor
0,094  0,019  Estrogen agonist
0,206  0,130  Transcription factor STAT inhibitor
0,115  0,040  Antineoplastic antibiotic
0,125  0,051  Photosensitizer
0,125  0,051  Excitatory amino acid transporter EAAC1 inhibitor
0,108  0,035  Restless leg syndrome treatment
0,110  0,037  Antiviral (Rhinovirus)
0,234  0,161  Calpain 2 inhibitor
0,077  0,007  Dopamine D5 agonist
0,099  0,029  Thioredoxin reductase inhibitor
0,101  0,031  Na+ K+ transporting ATPase inhibitor
0,079  0,009  Ryanodine receptor antagonist
0,104  0,035  ATPase (Vacuolar H+) inhibitor
0,123  0,054  GABA receptor agonist
0,118  0,050  AMP-activated protein kinase stimulant
0,073  0,005  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,123  0,056  Caspase 3 inhibitor
0,122  0,056  Transcription factor STAT6 inhibitor
0,125  0,060  Protein-tyrosine phosphatase 1B inhibitor
0,089  0,024  Peroxisome proliferator-activated receptor gamma antagonist
0,081  0,016  Transcription factor RelA inhibitor
0,092  0,028  Dopamine D1 antagonist
0,111  0,048  Sphingomyelinase inhibitor
0,084  0,020  SULT2A1 substrate
0,080  0,018  Beta 1 adrenoreceptor antagonist
0,084  0,023  Glutamate (mGluR7) antagonist
0,112  0,051  GST T1-1 substrate
0,070  0,008  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,183  0,123  Peptidyltransferase inhibitor
0,072  0,014  Anesthetic inhalation
0,074  0,018  Postcoital contraceptive
0,063  0,007  Melatonin 2 agonist
0,080  0,027  Beta adrenoreceptor antagonist
0,114  0,061  Myasthenia Gravis treatment
0,078  0,028  Protease 3C (Human rhinovirus) inhibitor
0,073  0,023  Calcium channel P-type blocker
0,137  0,088  NOS3 expression enhancer
0,058  0,009  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,233  0,184  CYP2C9 inhibitor
0,106  0,058  Adenylate kinase inhibitor
0,083  0,035  Glycine receptor agonist
0,137  0,089  Antidiarrheal
0,096  0,048  Phosphodiesterase IV inhibitor
0,178  0,131  Antidiabetic symptomatic
0,129  0,083  Antiparkinsonian, tremor relieving
0,088  0,042  Phosphodiesterase 4D inhibitor
0,123  0,077  Cyclooxygenase 1 inhibitor
0,077  0,031  CDC25B inhibitor
0,111  0,065  Endometrios treatment
0,125  0,080  Contraceptive
0,064  0,019  CD45 antagonist
0,063  0,019  Potassium channel Kv1.3 blocker
0,073  0,029  Antiviral (Parainfluenza)
0,049  0,005  Glutamate (mGluR3) agonist
0,102  0,059  Anticataract
0,064  0,020  Beta 2 adrenoreceptor antagonist
0,154  0,111  P-glycoprotein inhibitor
0,139  0,099  Muscle relaxant
0,090  0,050  Antispirochetal
0,083  0,043  Narcotic antagonist
0,077  0,039  Dopamine agonist
0,052  0,014  Inosine monophosphate dehydrogenase inhibitor
0,112  0,074  DNA polymerase I inhibitor
0,127  0,090  Cyclooxygenase inhibitor
0,151  0,114  Non-steroidal antiinflammatory agent
0,165  0,128  Antineoplastic enhancer
0,082  0,045  Antibiotic
0,057  0,021  Glucose-6-phosphate isomerase inhibitor
0,075  0,039  Anticholelithogenic
0,079  0,044  Antitreponemal
0,070  0,035  Neuraminidase (influenza) inhibitor
0,046  0,012  Sodium-dependent vitamin C transporter 2 inhibitor
0,055  0,022  Dopamine beta hydroxylase inhibitor
0,098  0,065  Glutamate (mGluR7) agonist
0,081  0,048  Antidote, organophosphates
0,044  0,012  Nucleoside transporters inhibitor
0,101  0,069  Falcipain 3 inhibitor
0,128  0,096  Antidote
0,057  0,026  Phosphorylase inhibitor
0,064  0,033  Fibroblast growth factor 4 antagonist
0,086  0,056  Myeloperoxidase inhibitor
0,073  0,042  Protein kinase C beta inhibitor
0,151  0,122  Angiogenesis stimulant
0,044  0,016  Glutamate (mGluR8) agonist
0,099  0,071  Toll-Like receptor 4 antagonist
0,143  0,116  Antineoplastic (gastric cancer)
0,091  0,064  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,063  0,037  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,068  0,042  Leukotriene antagonist
0,031  0,007  Inosine monophosphate dehydrogenase 2 inhibitor
0,070  0,047  Elastase 1 inhibitor
0,070  0,046  Carbonic anhydrase VA inhibitor
0,029  0,006  GABA transporter inhibitor
0,100  0,077  Chelator
0,089  0,066  Uric acid excretion stimulant
0,039  0,016  Melatonin 1 agonist
0,088  0,066  Glutamate release inhibitor
0,079  0,057  Platelet growth factor antagonist
0,041  0,019  Vanilloid 3 antagonist
0,041  0,019  Phosphoglycerate kinase inhibitor
0,049  0,028  Dopamine D2 agonist
0,042  0,021  Estrogen receptor beta agonist
0,105  0,085  Antiprotozoal (Babesia)
0,055  0,034  Leukotriene B4 antagonist
0,064  0,044  Beta 3 adrenoreceptor antagonist
0,128  0,107  Hexokinase inhibitor
0,051  0,031  Plasminogen activator inhibitor antagonist
0,051  0,032  Carbonic anhydrase XIV inhibitor
0,215  0,197  Antineoplastic (endocrine cancer)
0,023  0,005  Granulocyte colony stimulating factor receptor agonist
0,071  0,054  Catalase inhibitor
0,065  0,048  Carbonic anhydrase V inhibitor
0,050  0,033  Factor III inhibitor
0,047  0,030  Purinergic P2X4 antagonist
0,060  0,043  Antidote, heavy metal
0,110  0,095  Bone formation stimulant
0,101  0,086  Acetylcholine release stimulant
0,065  0,050  Cyclin B3 inhibitor
0,110  0,095  DNA repair enzyme inhibitor
0,118  0,103  Sphingosine 1-phosphate receptor 2 antagonist
0,046  0,032  Carbonic anhydrase VII inhibitor
0,051  0,037  Aconitate hydratase inhibitor
0,044  0,030  Dihydrofolate reductase inhibitor
0,091  0,077  GABA C receptor rho-1 antagonist
0,055  0,041  Adenine nucleotide translocase inhibitor
0,070  0,057  CDC25A inhibitor
0,097  0,084  Interleukin 1b antagonist
0,054  0,041  Dihydroorotate oxidase inhibitor
0,120  0,107  Antiprotozoal (Coccidial)
0,133  0,121  Sedative
0,079  0,066  GABA A receptor agonist
0,025  0,013  Dopamine D1 agonist
0,058  0,046  Dopamine D3 antagonist
0,049  0,037  Prolyl endopeptidase inhibitor
0,133  0,122  Amyloid beta precursor protein antagonist
0,058  0,047  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,026  0,016  Complement factor 1s inhibitor
0,185  0,175  Thyroid hormone antagonist
0,029  0,019  Estrogen-related receptor gamma antagonist
0,147  0,138  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,019  0,010  Alpha 2a adrenoreceptor agonist
0,108  0,098  Antiviral (Influenza B)
0,183  0,174  Hepatic disorders treatment
0,019  0,010  Antibiotic Trimethoprim-like
0,034  0,025  Tubulin agonist
0,036  0,028  5-Alpha-reductase inhibitor
0,020  0,012  Antibiotic Anthracycline-like
0,057  0,050  Bcl-xL inhibitor
0,057  0,050  Transcription factor AP-1 inhibitor
0,037  0,030  Alpha 1d adrenoreceptor agonist
0,031  0,024  Melatonin agonist
0,031  0,024  Estrogen-related receptor alpha antagonist
0,050  0,043  Alpha-mannosidase inhibitor
0,176  0,170  Transcription factor STAT3 inhibitor
0,040  0,034  Guanylate cyclase inhibitor
0,146  0,140  Antiulcerative
0,087  0,082  Bile acid receptor antagonist
0,036  0,031  Dopamine D3 agonist
0,027  0,022  Hedgehog signaling activator
0,110  0,106  Antiprotozoal (Trichomonas)
0,179  0,175  Thyroid hormone beta antagonist
0,013  0,009  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,051  0,047  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,031  0,028  Progesterone antagonist
0,049  0,046  Protein kinase C eta inhibitor
0,106  0,104  Toll-Like receptor 9 antagonist
0,063  0,061  Exportin-1 inhibitor
0,073  0,071  MAP kinase kinase 7 inhibitor
0,103  0,101  Cyclooxygenase 2 inhibitor
0,018  0,016  Peroxisome proliferator-activated receptor alpha antagonist
0,006  0,004  Insulin like growth factor 3 antagonist
0,053  0,052  Neuraminidase inhibitor
0,039  0,038  GABA B receptor antagonist
0,054  0,053  Heat shock protein 90 beta antagonist
0,014  0,014  Antibiotic Tetracycline-like
0,085  0,085  Chronic obstructive bronchitis treatment
0,092  0,092  GABA C receptor antagonist
0,058  0,058  Beta 2 adrenoreceptor agonist

